China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- Exhibition celebrates 1st anniversary of Olympic qualifier series in Shanghai
- Seal engraving exhibition opens in Beijing to celebrate Int'l Day of Families
- Call for Entries: International Cartoon and Illustration Exhibition 2025
- China's commercial rocket sends six satellites into space
- Call for Entries: International Cartoon and Illustration Exhibition 2025
- Tangled in debates, AI makes an entry to salons
